Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page
- Check4 days agoChange DetectedAdded Carcinoid tumor to MeSH terms and included a Resources section for Genetic and Rare Diseases Information Center. Revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 of the page framework. The trial-specific content remains unchanged.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a new revision tag 'Revision: v3.4.2'. Removed older maintenance notices including the funding-lapse notice and 'Revision: v3.4.1'.SummaryDifference0.4%

- Check47 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operations was added, and the page version updated from v3.4.0 to v3.4.1, with no modifications to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedUI text updates include a Show glossary label, the Last Update Submitted that Met QC Criteria entry, the No FEAR Act Data indicator, and the Revision: v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedRevision entry updated from v3.3.3 to v3.3.4, adding the new version label and removing the previous one.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.